Back to results
US 3,944,524 AGranted
4-Substituted-1-piperidinesulfonamides
AssigneePfizer Inc.
InventorsGeorge R. Evanega, Donald E. Kuhla, Reinhard Sarges
Life of this patent
Estimating the term…
Abstract
A series of novel 1-piperidinesulfonylurea compounds derived from a nitrogen-containing monocarboxylic acid have been prepared by reacting an appropriate sulfamide with an organic isocyanate or a trisubstituted urea equivalent thereof. The sulfamylureas so obtained are useful in therapy as oral hypoglycemic agents. Typical members include those compounds derived from 2-methoxynicotinic acid, of which 1-(bicyclo[2.2.1]hept-5-en-2-yl-endomethyl)-3-{4-[2-(2-methoxynicotinamido )ethyl]-1-piperidinesulfonyl}urea is a most preferred embodiment.
Claims3
A sulfamide compound of the formula:
- ##SPC4##
- wherein R is a member selected from the group consisting of 2-methoxy-3-pyridyl 2-ethoxy-3-pyridyl and 4-chloro-2-pyridyl.
Dependencies are inferred from the claim text.